Jennifer Michaelson - 20 Mar 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Chief Development Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
20 Mar 2023
Net transactions value
-$2,694
Form type
4
Filing time
27 Mar 2023, 16:05:24 UTC
Previous filing
21 Feb 2023
Next filing
14 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale $2,694 -238 -0.26% $11.32 91,293 20 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.